CITRAVESCENT granules sachet (reformulation)

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

sodium bicarbonate, Quantity: 1.32 g; citric acid, Quantity: 1.23 g; tartaric acid, Quantity: 0.4 g; sodium carbonate, Quantity: 0.08 g

Beschikbaar vanaf:

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare

INN (Algemene Internationale Benaming):

citric acid,sodium bicarbonate,sodium carbonate,tartaric acid

farmaceutische vorm:

Granules, effervescent

Samenstelling:

Excipient Ingredients: lactose monohydrate; sucrose

Toedieningsweg:

Oral

Eenheden in pakket:

8 sachets, 10 sachets, 25 sachets, 28 sachets, 20 sachets

Prescription-type:

Not scheduled. Not considered by committee

therapeutische indicaties:

Systemic and urinary alkalinisation where indicated in the relief of symptoms associated with urinary tract infections such as cystitis, pyelonephritis, urethritis; and in reducing the formation of uric acid and cystine calculi. Citravescent may increase the effectiveness of sulphonamide antibiotics in the treatment of urinary tract infection. Acid indigestion or heartburn.

Product samenvatting:

Visual Identification: White granules; Container Type: Sachet; Container Material: Al laminated with LDPE/paper; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2013-08-15